Healthcare -
Biotechnology - NASDAQ - US
$ 15.04
-3.16 %
$ 1.19 B
Market Cap
-3.48
P/E
VRDN - REVENUE
Revenue VRDN - Viridian Therapeutics, Inc.
314 K
LAST VALUE
-67.45%
2 YEAR CAGR
-48.16%
5 YEAR CAGR
-23.06%
10 YEAR CAGR